Evolent Health, Inc. (EVH)
USD 10.71
(-1.47%)
USD 10.71
(-1.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 451.97 Million USD | 56.98% |
| 2022 | 287.91 Million USD | 1929.45% |
| 2021 | 14.18 Million USD | -26.47% |
| 2020 | 19.29 Million USD | -92.8% |
| 2019 | 267.78 Million USD | 3778.88% |
| 2018 | -7.27 Million USD | 93.78% |
| 2017 | -117.03 Million USD | -719.6% |
| 2016 | -14.28 Million USD | 90.2% |
| 2015 | -145.72 Million USD | 0.0% |
| 2014 | - USD | 100.0% |
| 2013 | -67.89 Million USD | -1192.67% |
| 2012 | -5.25 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 607.61 Million USD | 34.44% |
| 2024 Q2 | 698.6 Million USD | 14.97% |
| 2023 Q4 | 451.97 Million USD | -3.63% |
| 2023 FY | 451.97 Million USD | 56.98% |
| 2023 Q2 | 553.27 Million USD | 16.54% |
| 2023 Q3 | 469.01 Million USD | -15.23% |
| 2023 Q1 | 474.75 Million USD | 64.89% |
| 2022 Q4 | 287.91 Million USD | -10.19% |
| 2022 FY | 287.91 Million USD | 1929.45% |
| 2022 Q3 | 320.58 Million USD | 106.78% |
| 2022 Q2 | 155.03 Million USD | 14.64% |
| 2022 Q1 | 135.23 Million USD | 853.26% |
| 2021 Q3 | 49.28 Million USD | -46.32% |
| 2021 Q1 | 60.53 Million USD | 213.78% |
| 2021 Q2 | 91.81 Million USD | 51.67% |
| 2021 FY | 14.18 Million USD | -26.47% |
| 2021 Q4 | 14.18 Million USD | -71.21% |
| 2020 Q1 | 295.47 Million USD | 10.34% |
| 2020 Q3 | -13.12 Million USD | -106.51% |
| 2020 Q4 | 19.29 Million USD | 246.99% |
| 2020 FY | 19.29 Million USD | -92.8% |
| 2020 Q2 | 201.47 Million USD | -31.81% |
| 2019 Q4 | 267.78 Million USD | 29.23% |
| 2019 FY | 267.78 Million USD | 3778.88% |
| 2019 Q1 | 52.5 Million USD | 821.29% |
| 2019 Q3 | 207.21 Million USD | -0.51% |
| 2019 Q2 | 208.26 Million USD | 296.67% |
| 2018 FY | -7.27 Million USD | 93.78% |
| 2018 Q4 | -7.27 Million USD | 92.7% |
| 2018 Q3 | -99.75 Million USD | -31.03% |
| 2018 Q2 | -76.13 Million USD | 3.26% |
| 2018 Q1 | -78.69 Million USD | 32.76% |
| 2017 Q2 | 20.96 Million USD | 27.72% |
| 2017 Q3 | -165.97 Million USD | -891.88% |
| 2017 FY | -117.03 Million USD | -719.6% |
| 2017 Q1 | 16.41 Million USD | 214.92% |
| 2017 Q4 | -117.03 Million USD | 29.49% |
| 2016 FY | -14.28 Million USD | 90.2% |
| 2016 Q1 | -111.29 Million USD | 23.63% |
| 2016 Q2 | -105.13 Million USD | 5.53% |
| 2016 Q4 | -14.28 Million USD | 86.99% |
| 2016 Q3 | -109.77 Million USD | -4.41% |
| 2015 Q1 | -12.59 Million USD | 0.0% |
| 2015 Q2 | -219.36 Million USD | -1642.25% |
| 2015 Q4 | -145.72 Million USD | 29.99% |
| 2015 Q3 | -208.15 Million USD | 5.11% |
| 2015 FY | -145.72 Million USD | 0.0% |
| 2014 FY | - USD | 100.0% |
| 2014 Q1 | 67.89 Million USD | 200.0% |
| 2014 Q4 | - USD | 100.0% |
| 2014 Q3 | -16.25 Million USD | 0.0% |
| 2013 FY | -67.89 Million USD | -1192.67% |
| 2013 Q4 | -67.89 Million USD | 0.0% |
| 2012 FY | -5.25 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Well Corporation | -360.25 Million USD | 225.46% |
| Doximity, Inc. | -82.23 Million USD | 649.582% |
| MultiPlan Corporation | 4.48 Billion USD | 89.926% |
| Phreesia, Inc. | -75.53 Million USD | 698.344% |
| Teladoc Health, Inc. | 468.6 Million USD | 3.549% |
| Veeva Systems Inc. | -647.71 Million USD | 169.78% |